Medical University of Vienna
Vienna, Austria
Josef Smolen received his MD degree from the University of Vienna, Austria, and trained there in Immunology, Medicine and Rheumatology. He was a research fellow at the Arthritis Institute at NIH, Bethesda, MD, USA. From 1989 to 2017 he has been Chairman, 2nd Department of Medicine, Hietzing Hospital, Vienna; 1995-2018 he served as Professor of Medicine and Chairman, Division of Rheumatology, Medical University of Vienna, where he also acted as Chairman of the Department of Medicine 3 from 2007 to 2018. He is now Emeritus Professor of Medicine at the Medical University of Vienna, Austria.
An author of several hundred original publications and lead investigator of many clinical trials, his major scientific interests concern elucidation of the pathogenesis of rheumatic diseases, translational research, outcomes and epidemiologic research, as well as novel therapies and therapeutic strategies in rheumatic diseases.
Josef Smolen was President of EULAR from 2003 to 2005 and President of the Austrian Society of Rheumatology and Austrian Society of Immunology. He is a member of the Austrian Academy of Sciences, the German Academy of Sciences (Leopoldina), Fellow of the Royal College of Physicians (London) and Honorary Doctor of Lund University, Sweden, Leiden University, Netherlands, and Semmelweis University, Budapest. He is a co-editor of the textbook “Rheumatology” whose 9th edition is in preparation. He currently serves as editor-in-chief of Annals of the Rheumatic Diseases.
14T110: Editor's Picks 2023: Arthritis & Rheumatology and Annals of the Rheumatic Diseases
Tuesday, November 14, 2023
7:30 AM – 9:00 AM PT
Disclosure(s): AbbVie: Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Amgen: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Annals of the Rheumatic Diseases: Editor (Ongoing); AstraZeneca: Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Astro: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Bristol-Myers Squibb: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Celgene: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Celltrion: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Chugai: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Eli Lilly: Grant/Research Support (Ongoing); EULAR Task Forces and T2T Task Forces: Convenor (Ongoing); Gilead: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); ILTOO: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Janssen: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Lilly: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Merck Sharp & Dohme: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Novartis: Grant/Research Support (Ongoing); Novartis-Sandoz: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Pfizer: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Rheumatology 7E/8E: Co-editor (Ongoing); Roche: Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); R-Pharma: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Samsung: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Sanofi: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); UCB Pharma: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Tuesday, November 14, 2023
7:30 AM – 7:35 AM PT
Disclosure(s): AbbVie: Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Amgen: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Annals of the Rheumatic Diseases: Editor (Ongoing); AstraZeneca: Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Astro: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Bristol-Myers Squibb: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Celgene: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Celltrion: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Chugai: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Eli Lilly: Grant/Research Support (Ongoing); EULAR Task Forces and T2T Task Forces: Convenor (Ongoing); Gilead: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); ILTOO: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Janssen: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Lilly: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Merck Sharp & Dohme: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Novartis: Grant/Research Support (Ongoing); Novartis-Sandoz: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Pfizer: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Rheumatology 7E/8E: Co-editor (Ongoing); Roche: Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); R-Pharma: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Samsung: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Sanofi: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); UCB Pharma: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Tuesday, November 14, 2023
9:00 AM – 11:00 AM PT
Disclosure(s): AbbVie: Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Amgen: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Annals of the Rheumatic Diseases: Editor (Ongoing); AstraZeneca: Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Astro: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Bristol-Myers Squibb: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Celgene: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Celltrion: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Chugai: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Eli Lilly: Grant/Research Support (Ongoing); EULAR Task Forces and T2T Task Forces: Convenor (Ongoing); Gilead: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); ILTOO: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Janssen: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Lilly: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Merck Sharp & Dohme: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Novartis: Grant/Research Support (Ongoing); Novartis-Sandoz: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Pfizer: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Rheumatology 7E/8E: Co-editor (Ongoing); Roche: Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); R-Pharma: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Samsung: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Sanofi: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); UCB Pharma: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
